FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer

The U.S. FDA has authorised a clinical trial at the University of Colorado Anschutz to test a novel CAR T-cell therapy targeting B7-H3 and IL-8 in advanced colorectal cancer and solid tumours, aiming to improve treatment for a wider patient group with solid tumours that currently have few immunotherapy options.

This Wire brief sits within Fusion42's coverage of Biotech.